Skip to main content
Biochemical Journal logoLink to Biochemical Journal
. 1990 Feb 1;265(3):841–847. doi: 10.1042/bj2650841

Transition of affinity states for leukotriene B4 receptors in sheep lung membranes.

B Votta 1, S Mong 1
PMCID: PMC1133708  PMID: 2154970

Abstract

Leukotriene B4 (LTB4) is a pro-inflammatory arachidonate metabolite. We have characterized the LTB4 receptors in sheep lung membranes and have assessed the contribution of the guanine-nucleotide-binding (G) protein in the regulation of receptor affinity states. Saturation isotherms have demonstrated a single class of LTB4 receptor with a Kd of 0.18 +/- 0.03 nM and a density (Bmax.) of 410 +/- 84 fmol/mg of protein in sheep lung membranes. The effect of the G-protein on receptor affinity was assessed in the presence of non-hydrolysable GTP analogues (e.g. GTP[S]) and in membranes following alkali treatment (pH 12.1) to remove the G-protein. Saturation isotherms produced either in the presence of GTP[S] (Kd.GTP[S] = 0.51 +/- 0.02 nM) or with alkali-treated membranes (Kd.alk. = 0.52 +/- 0.02 nM) demonstrated a 3-fold shift in receptor affinity for [3H]LTB4 binding. In competition experiments, the rank order of affinity of LTB4 analogues was LTB4 greater than 20-OH-LTB4 greater than trans-homo-LTB4 greater than 6-trans-LTB4 greater than 20-COOH-LTB4, using either untreated or alkali-treated membranes, both in the presence and absence of GTP[S]. These findings demonstrate that, in sheep lung membranes, there is only one class of LTB4 receptor. Removal of the G-protein or uncoupling of the receptor from the G-protein shifted the agonist-binding affinity of the receptor by 3-4-fold, without affecting the specificity of the LTB4 receptor in either the high- or the low-affinity state.

Full text

PDF
841

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bomalaski J. S., Mong S. Binding of leukotriene B4 and its analogs to human polymorphonuclear leukocyte membrane receptors. Prostaglandins. 1987 Jun;33(6):855–867. doi: 10.1016/0090-6980(87)90114-6. [DOI] [PubMed] [Google Scholar]
  2. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  3. Cheng J. B., Cheng E. I., Kohi F., Townley R. G. [3H]leukotriene B4 binding to the guinea-pig spleen membrane preparation: a rich tissue source for a high-affinity leukotriene B4 receptor site. J Pharmacol Exp Ther. 1986 Jan;236(1):126–132. [PubMed] [Google Scholar]
  4. Cheng Y., Prusoff W. H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol. 1973 Dec 1;22(23):3099–3108. doi: 10.1016/0006-2952(73)90196-2. [DOI] [PubMed] [Google Scholar]
  5. Clancy R. M., Dahinden C. A., Hugli T. E. Oxidation of leukotrienes at the omega end: demonstration of a receptor for the 20-hydroxy derivative of leukotriene B4 on human neutrophils and implications for the analysis of leukotriene receptors. Proc Natl Acad Sci U S A. 1984 Sep;81(18):5729–5733. doi: 10.1073/pnas.81.18.5729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. De Lean A., Stadel J. M., Lefkowitz R. J. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. J Biol Chem. 1980 Aug 10;255(15):7108–7117. [PubMed] [Google Scholar]
  7. Ford-Hutchinson A. W. Leukotrienes: their formation and role as inflammatory mediators. Fed Proc. 1985 Jan;44(1 Pt 1):25–29. [PubMed] [Google Scholar]
  8. Goldman D. W., Chang F. H., Gifford L. A., Goetzl E. J., Bourne H. R. Pertussis toxin inhibition of chemotactic factor-induced calcium mobilization and function in human polymorphonuclear leukocytes. J Exp Med. 1985 Jul 1;162(1):145–156. doi: 10.1084/jem.162.1.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Goldman D. W., Gifford L. A., Marotti T., Koo C. H., Goetzl E. J. Molecular and cellular properties of human polymorphonuclear leukocyte receptors for leukotriene B4. Fed Proc. 1987 Jan;46(1):200–203. [PubMed] [Google Scholar]
  10. Goldman D. W., Gifford L. A., Olson D. M., Goetzl E. J. Transduction by leukotriene B4 receptors of increases in cytosolic calcium in human polymorphonuclear leukocytes. J Immunol. 1985 Jul;135(1):525–530. [PubMed] [Google Scholar]
  11. Goldman D. W., Goetzl E. J. Heterogeneity of human polymorphonuclear leukocyte receptors for leukotriene B4. Identification of a subset of high affinity receptors that transduce the chemotactic response. J Exp Med. 1984 Apr 1;159(4):1027–1041. doi: 10.1084/jem.159.4.1027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Goldman D. W., Goetzl E. J. Selective transduction of human polymorphonuclear leukocyte functions by subsets of receptors for leukotriene B4. J Allergy Clin Immunol. 1984 Sep;74(3 Pt 2):373–377. doi: 10.1016/0091-6749(84)90133-7. [DOI] [PubMed] [Google Scholar]
  13. Hoffstein S. T., Manzi R. M., Razgaitis K. A., Bender P. E., Gleason J. Structural requirements for chemotactic activity of leukotriene B4 (LTB4). Prostaglandins. 1986 Feb;31(2):205–215. doi: 10.1016/0090-6980(86)90047-x. [DOI] [PubMed] [Google Scholar]
  14. Kilpatrick B. F., Caron M. G. Agonist binding promotes a guanine nucleotide reversible increase in the apparent size of the bovine anterior pituitary dopamine receptors. J Biol Chem. 1983 Nov 25;258(22):13528–13534. [PubMed] [Google Scholar]
  15. Kreisle R. A., Parker C. W., Griffin G. L., Senior R. M., Stenson W. F. Studies of leukotriene B4-specific binding and function in rat polymorphonuclear leukocytes: absence of a chemotactic response. J Immunol. 1985 May;134(5):3356–3363. [PubMed] [Google Scholar]
  16. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  17. Lawson C., Bunting S., Holzgrefe H., Fitzpatrick F. Leukotriene B4 and 20-hydroxyleukotriene B4 contract guinea-pig trachea strips in vitro. J Pharmacol Exp Ther. 1986 Jun;237(3):888–892. [PubMed] [Google Scholar]
  18. Matsumoto T., Molski T. F., Kanaho Y., Becker E. L., Sha'afi R. I. G-protein dissociation, GTP-GDP exchange and GTPase activity in control and PMA treated neutrophils stimulated by fMet-Leu-Phe. Biochem Biophys Res Commun. 1987 Mar 13;143(2):489–498. doi: 10.1016/0006-291x(87)91380-5. [DOI] [PubMed] [Google Scholar]
  19. Michel T., Hoffman B. B., Lefkowitz R. J. Differential regulation of the alpha 2-adrenergic receptor by Na+ and guanine nucleotides. Nature. 1980 Dec 25;288(5792):709–711. doi: 10.1038/288709a0. [DOI] [PubMed] [Google Scholar]
  20. Mong S., Chi-Rosso G., Miller J., Hoffman K., Razgaitis K. A., Bender P., Crooke S. T. Leukotriene B4 induces formation of inositol phosphates in rat peritoneal polymorphonuclear leukocytes. Mol Pharmacol. 1986 Sep;30(3):235–242. [PubMed] [Google Scholar]
  21. O'Flaherty J., Kosfeld S., Nishihira J. Binding and metabolism of leukotriene B4 by neutrophils and their subcellular organelles. J Cell Physiol. 1986 Mar;126(3):359–370. doi: 10.1002/jcp.1041260306. [DOI] [PubMed] [Google Scholar]
  22. Saad M., Wong K. Specific binding of leukotriene B4 to guinea pig lung membranes. Biochem Biophys Res Commun. 1987 Feb 27;143(1):364–371. doi: 10.1016/0006-291x(87)90674-7. [DOI] [PubMed] [Google Scholar]
  23. Samuelsson B. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science. 1983 May 6;220(4597):568–575. doi: 10.1126/science.6301011. [DOI] [PubMed] [Google Scholar]
  24. Showell H. J., Naccache P. H., Borgeat P., Picard S., Vallerand P., Becker E. L., Sha'afi R. I. Characterization of the secretory activity of leukotriene B4 toward rabbit neutrophils. J Immunol. 1982 Feb;128(2):811–816. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES